IFV News speaks with Dr. Robert McNally, President and CEO of GeoVax Labs. This small Georgia based biotech company is the leading vaccine candidate for prevention of HIV. Dr. McNally tells us about the work of Harriet L. Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs and her team. They've recently announced the results of a study suggesting that scientists may be one step closer to a vaccine that protects against multiple exposures to HIV infections. GeoVax speaks with us from Rodman and Renshaw in NYC, this investment bank provides a number of services to public and private companies across multiple sectors; it also services institutional investors.
Business news program that focuses on midcap, smallcap and microcap companies around the globe, as well as other medium and small businesses, and entrepreneurial endeavors. Show airs every Saturday at http://www.ifvnews.com. IFV NEWS is a product of M.INK Productions® LLC (http://www.minkproductions.tv)
